SBI Shinsei Bank, a subsidiary of Japan’s SBI Holdings, is preparing to file for a relisting on the Tokyo Stock Exchange (TSE) as early as July, according to two sources familiar with the matter. The bank is targeting a public debut by year-end, aiming to secure a valuation of approximately 1.5 trillion yen ($10.46 billion), one of the sources said.
If successful, the IPO would be among Japan's largest recent listings, reflecting the strong momentum in the local equities market. The Nikkei 225 has been hovering near record highs, driving a wave of high-profile IPOs. SBI Shinsei’s expected valuation would nearly double that of JX Advanced Metals, which went public in March.
The move comes amid growing investor appetite for financial sector exposure, especially as Japanese firms take advantage of bullish market conditions. While the IPO plans have not been publicly confirmed, the individuals familiar with the situation requested anonymity as the discussions remain private.
SBI Holdings issued a statement acknowledging that it has long considered a relisting of SBI Shinsei Bank but noted it is unaware of any specific filing timeline or listing date at this stage.
The relisting of SBI Shinsei Bank would mark a significant shift in the bank’s strategic trajectory, potentially boosting its capital base and expanding market visibility. It also underscores the broader trend of Japanese companies tapping into capital markets to unlock shareholder value amid a buoyant economic backdrop.
Investors and analysts will be closely watching for an official filing in the coming weeks as the Japanese IPO market continues to attract significant interest.


Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Instagram Outage Disrupts Thousands of U.S. Users
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 



